Alkermes
VC Fund
Dublin, Ireland
Alkermes is a VC fund in Dublin focused on Non Profit and Charity. Alkermes, Inc. is an integrated biotechnology company. The Company is engaged in the business of developing, manufacturing and commercializing medicines for the treatment of prevalent, chronic diseases. Alkermes, Inc. develops, manufactures and commercializes VIVITROL for alcohol dependence and manufacture RISPERDAL CONSTA for schizophrenia andbipolar I disorder. Its pipeline includes extended-release injectable and oral products for the treatment of prevalent, chronic diseases, such as central nervous system (CNS), disorders, reward disorders, addiction, diabetes and autoimmune disorders. The Company has a research facility in Massachusetts and a commercial manufacturing facility in Ohio. RISPERDAL CONSTA is used for the treatment of schizophrenia and for the treatment of bipolar I disorder. VIVITROL is an extended-release MEDISORB formulation of naltrexone, as a once-monthly injectable medication for the treatment of alcohol dependence.
- Total investments:
- 15
- Last investment:
- Lead investor:
- 87%
Last updated:
For AI agents: llms.txt
Industries Alkermes invests in
Stages Alkermes invests in
Countries Alkermes invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Georgianna Harris
|
|||
|
Paul Mitchell
|
|||
Shane Cooke
|
|||
Craig Hopkinson
|
|||
David Daglio
|
Investment Focus
Industry
- Non Profit 11 (73%)
- Charity 3 (20%)
- Health Care 3 (20%)
- Legal 2 (13%)
- Fitness 2 (13%)
Stage
- Grant 12 (80%)
- Series B 1 (7%)
- Series C 1 (7%)
- Corporate Round 1 (7%)
Country
- United States 13 (87%)
- Ireland 1 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Georgianna Harris
Vice President of Regulatory Affairs
|
Vice President of Regulatory Affairs | Total investments: 0 | Find email | |
|
Paul Mitchell
Member of the Board of Directors
|
Member of the Board of Directors | Total investments: 0 | Find email | |
|
Shane Cooke
President
|
President | Total investments: 0 | Find email | |
|
Craig Hopkinson
CMO and Head of Clinical Development and Medical Affairs
|
CMO and Head of Clinical Development and Medical Affairs | Total investments: 0 | Find email | |
|
David Daglio
Non Executive Director
|
Non Executive Director | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Mural Oncology
|
Mural Oncology is an independent public company. Mural Oncology would focus on the discovery and development of cancer therapies, including the continued development of nemvaleukin alfa and the company's portfolio of novel, preclinical engineered cytokines, comprised of tumor-targeted split interleukin-12 (IL-12) and interleukin-18 (IL-18). | $275M / Corporate Round / Nov 15, 2023 | |
She Recovers Foundation
|
She Recovers Foundation is a non-profit organization dedicated to redefining recovery, inspiring hope, eradicating stigma, and empowering women in or seeking recovery to expand their recovery capital, heal themselves, and assist other women in doing the same. | Grant / Aug 31, 2023 | |
NAMI Mobile
|
NAMI Mobile promotes free mental illness education, support, and advocacy to individuals in need. | Grant / Aug 31, 2023 | |
American Psychiatric Association
|
The American Psychiatric Association is an organization of psychiatrists that offers diagnosis services and treatment for persons with mental disorders, including intellectual disabilities and substance use disorders. The society’s Diagnostic and Statistical Manual of Mental Disorders (DSM) is the standard classification of mental disorders used bymental health professionals in the United States, which contains a listing of diagnostic criteria for every psychiatric disorder recognized by the U.S. healthcare system.The American Psychiatric Association was founded in 1844 and is based in Virginia, United States. | Grant / Aug 31, 2023 | |
CSG Justice Center
|
CSG Justice Center is a non-profit organization that specializes in safety and second chances, along with providing assistance. | Grant / Aug 31, 2023 | |
The Recovery Community Network
|
The Recovery Community Network is a non-profit, grassroots Recovery Community Organization dedicated to mobilizing resources inside and outside of the recovery community to enhance the prevalence of and access to substance use disorder recovery. | Grant / Aug 31, 2023 | |
Caregiver Action Network
|
Caregiver Action Network offers education, peer support, and resources to family caregivers across the country. | Grant / Aug 31, 2023 | |
Foundation for Women's Cancer
|
FWC is a non profit that provides funding for gynecologic cancer research and training, educational programs and resources. | Grant / Aug 31, 2023 | |
Ohio Chamber of Commerce Research Foundation
|
Ohio Chamber of Commerce Research Foundation is a non-profit organization focused on delivering research and data that will drive and promote a healthy economy. | Grant / Aug 31, 2023 | |
Cancer Legal Care
|
Cancer Legal Care provides compassionate and caring free legal services. | Grant / Aug 31, 2023 | |
| See all 15 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Alkermes invest in?
Alkermes invests primarily in Non Profit, Charity and Health Care startups, most often at Grant and Series B stage. Most of the 15 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Alkermes?
Public channels for Alkermes include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Alkermes?
The team at Alkermes includes Georgianna Harris (Vice President of Regulatory Affairs), Paul Mitchell (Member of the Board of Directors) and Shane Cooke (President), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
